Literature DB >> 10672138

Secular changes in cardiovascular risk factors over 30 years in Swedish men aged 50: the study of men born in 1913, 1923, 1933 and 1943.

A Rosengren1, H Eriksson, B Larsson, K Svärdsudd, G Tibblin, L Welin, L Wilhelmsen.   

Abstract

OBJECTIVES: To study secular trends in cardiovascular risk factors in men aged 50 over a period of 30 years.
DESIGN: Cross-sectional studies of successive cohorts of men from 1963 to 1993.
SETTING: City of Göteborg, Sweden.
SUBJECTS: Four random population samples of men born in 1913, 1923, 1933 and 1943, aged 50 when they were examined in 1963, 1973, 1983, and 1993 (n = 855, 226, 776, and 798, respectively). MAIN OUTCOME MEASURES: Anthropometric measurements, blood pressure, serum cholesterol and triglycerides and smoking habits over three decades.
RESULTS: Over 30 years, men increased in weight from a mean (SD) of 75.9 (11.0) kg to 82.8 (12.1) kg and gained 3.4 cm in height, with a net increase in body mass index from 24.8 (3.2) to 26.0 (3.4) kg m-2 (P < 0.0001), and a concomitant increase in waist circumference. The proportion of men who were overweight but not obese (BMI = 25-30 kg m-2) increased from 38 to 47%, whereas the prevalence of frank obesity (more than 30 kg m-2) increased from 6% in 1963 to 11% in 1993. Despite the increase in weight, mean systolic blood pressure fell by almost 10 mmHg (P < 0.0001). Mean serum cholesterol concentration decreased from 6.42 (1.12) to 5.88 (1.04) (P < 0.0001). Serum triglycerides increased from 1.26 (0.77) to 1.69 (1.04) mmol L-1 (P = 0.001). The proportion of men who smoked decreased from 56% in 1963 to 30% in 1993 (P < 0.0001). This was due more to an increase in smoking cessation rates than to an increase in the proportion of men who had never smoked. In particular, smokers and former smokers are now more obese than the corresponding categories 30 years ago and smokers are no longer leaner than men who have never smoked.
CONCLUSIONS: Over a period of 30 years, serum cholesterol as well as systolic blood pressure and the prevalence of smoking decreased. This favourable decline in coronary risk factors was offset by an appreciable increase in body mass index and waist circumference.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10672138     DOI: 10.1046/j.1365-2796.2000.00589.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  9 in total

1.  Time trends in the incidence of myocardial infarction among professional drivers in Stockholm 1977-96.

Authors:  C Bigert; K Klerdal; N Hammar; J Hallqvist; P Gustavsson
Journal:  Occup Environ Med       Date:  2004-12       Impact factor: 4.402

2.  Biobank resources for future patient care: developments, principles and concepts.

Authors:  Akos Végvári; Charlotte Welinder; Henrik Lindberg; Thomas E Fehniger; György Marko-Varga
Journal:  J Clin Bioinforma       Date:  2011-09-16

3.  Global risk assessment for lipid therapy to prevent coronary heart disease.

Authors:  C M Nass; S D Wiviott; J K Allen; W S Post; a R Blumenthal
Journal:  Curr Cardiol Rep       Date:  2000-09       Impact factor: 2.931

4.  The effects of nicotine self-administration and withdrawal on concurrently available chow and sucrose intake in adult male rats.

Authors:  Patricia E Bunney; Danielle Burroughs; Christine Hernandez; Mark G LeSage
Journal:  Physiol Behav       Date:  2015-11-06

Review 5.  Large animal models of cardiovascular disease.

Authors:  H G Tsang; N A Rashdan; C B A Whitelaw; B M Corcoran; K M Summers; V E MacRae
Journal:  Cell Biochem Funct       Date:  2016-02-24       Impact factor: 3.685

6.  The common FTO variant rs9939609 is not associated with BMI in a longitudinal study on a cohort of Swedish men born 1920-1924.

Authors:  Josefin A Jacobsson; Ulf Risérus; Tomas Axelsson; Lars Lannfelt; Helgi B Schiöth; Robert Fredriksson
Journal:  BMC Med Genet       Date:  2009-12-09       Impact factor: 2.103

7.  The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases.

Authors:  J Danesh; S Erqou; M Walker; S G Thompson; R Tipping; C Ford; S Pressel; G Walldius; I Jungner; A R Folsom; L E Chambless; M Knuiman; P H Whincup; S G Wannamethee; R W Morris; J Willeit; S Kiechl; P Santer; A Mayr; N Wald; S Ebrahim; D A Lawlor; J W G Yarnell; J Gallacher; E Casiglia; V Tikhonoff; P J Nietert; S E Sutherland; D L Bachman; J E Keil; M Cushman; B M Psaty; R P Tracy; A Tybjaerg-Hansen; B G Nordestgaard; R Frikke-Schmidt; S Giampaoli; L Palmieri; S Panico; D Vanuzzo; L Pilotto; L Simons; J McCallum; Y Friedlander; F G R Fowkes; A J Lee; F B Smith; J Taylor; J Guralnik; C Phillips; R Wallace; D Blazer; K T Khaw; J H Jansson; C Donfrancesco; V Salomaa; K Harald; P Jousilahti; E Vartiainen; M Woodward; R B D'Agostino; P A Wolf; R S Vasan; M J Pencina; E M Bladbjerg; T Jorgensen; L Moller; J Jespersen; R Dankner; A Chetrit; F Lubin; A Rosengren; L Wilhelmsen; G Lappas; H Eriksson; C Bjorkelund; P Cremer; D Nagel; R Tilvis; T Strandberg; B Rodriguez; L M Bouter; R J Heine; J M Dekker; G Nijpels; C D A Stehouwer; E Rimm; J Pai; S Sato; H Iso; A Kitamura; H Noda; U Goldbourt; V Salomaa; J T Salonen; K Nyyssönen; T-P Tuomainen; D Deeg; J L Poppelaars; T Meade; J Cooper; B Hedblad; G Berglund; G Engstrom; A Döring; W Koenig; C Meisinger; W Mraz; L Kuller; R Selmer; A Tverdal; W Nystad; R Gillum; M Mussolino; S Hankinson; J Manson; B De Stavola; C Knottenbelt; J A Cooper; K A Bauer; R D Rosenberg; S Sato; Y Naito; I Holme; H Nakagawa; H Miura; P Ducimetiere; X Jouven; C Crespo; M Garcia-Palmieri; P Amouyel; D Arveiler; A Evans; J Ferrieres; H Schulte; G Assmann; J Shepherd; C Packard; N Sattar; B Cantin; B Lamarche; J-P Després; G R Dagenais; E Barrett-Connor; D Wingard; R Bettencourt; V Gudnason; T Aspelund; G Sigurdsson; B Thorsson; M Trevisan; J Witteman; I Kardys; M Breteler; A Hofman; H Tunstall-Pedoe; R Tavendale; G D O Lowe; Y Ben-Shlomo; B V Howard; Y Zhang; L Best; J Umans; A Onat; T W Meade; I Njolstad; E Mathiesen; M L Lochen; T Wilsgaard; J M Gaziano; M Stampfer; P Ridker; H Ulmer; G Diem; H Concin; F Rodeghiero; A Tosetto; E Brunner; M Shipley; J Buring; S M Cobbe; I Ford; M Robertson; Y He; A M Ibanez; E J M Feskens; D Kromhout; R Collins; E Di Angelantonio; S Kaptoge; S Lewington; L Orfei; L Pennells; P Perry; K Ray; N Sarwar; M Scherman; A Thompson; S Watson; F Wensley; I R White; A M Wood
Journal:  Eur J Epidemiol       Date:  2007-09-18       Impact factor: 8.082

Review 8.  Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension.

Authors:  Bin Zhou; Pablo Perel; George A Mensah; Majid Ezzati
Journal:  Nat Rev Cardiol       Date:  2021-05-28       Impact factor: 32.419

9.  Improved metabolic health among the obese in six population surveys 1986 to 2009: the Northern Sweden MONICA study.

Authors:  Martin Benckert; Mikael Lilja; Stefan Söderberg; Mats Eliasson
Journal:  BMC Obes       Date:  2015-02-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.